to maximize their impact on human health
needed to solve medicine's most challenging problems
meaningful clinical benefit and growing further discovery
The Latest News
-
Fellows in this brand-new program will complete a research project to gain hands-on experience in drug discovery and translational medicine. -
Sanford Burnham Prebys today announced that Professor Nicholas Cosford, Ph.D., will join the Institute’s Board of Trustees. -
The Institute came together to celebrate Erkki Ruoslahti, winner of the 2022 Albert Lasker Basic Medical Research Award. -
Moody's Investors Service has affirmed Sanford Burnham Prebys' (CA) A1 revenue bond rating. The institute had approximately $44 million of total debt outstanding as of June 30, 2022. The outlook is stable. -
Assistant Professor Lukas Chavez leverages modern technology for precision diagnostics and for uncovering new treatment options for the most aggressive childhood brain cancers - We asked him how these technologies are changing the game in cancer research. -
A top rating on Charity Navigator means Sanford Burnham Prebys is among the most trusted charities nationwide in terms of financial health and accountability -
President and CEO David A. Brenner recently spoke to the San Diego Business Journal about the future of the Institute and of the biomedical research sector. -
By inhibiting one enzyme, scientists from Sanford Burnham Prebys can kill prostate cancer cells when other treatments can’t -
Will Wang’s works at the intersection of biology and computer science to study how complex systems of cells interact and how these systems contribute to neuromuscular disease -
The Institute plans to recruit up to 20 new faculty positions in research areas including cancer, neurodegeneration and computational biology -
Patients with an incurable, genetic liver disease have new hope after an animal study showed that a single drug could reverse its effects -
Children's Health
Incurable liver disease may prove curable
Research from Sanford Burnham Prebys has found a drug that can spur liver regeneration in Alagille syndrome
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Years in the Making
Yasuyuki Kihara wins a dream award
Research Assistant Professor Yasuyuki Kihara, Ph.D., has won an Eicosanoid Research Foundation (ERF) Young Investigator Award, an award for researchers working in lipid biology.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
